You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither SPIE nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the SPIE website.
5 October 2009Point of care optical device for sepsis diagnosis
The discrimination of viral and bacterial sepsis is an important issue in intensive care patients. For this purpose, the
simultaneous measurements of different analytes are necessary. Among the possible candidates, C-reactive protein
(CRP) and procalcitonin (PCT) are probably the most important ones. A novel optical platform was designed and
realised for the implementation of fluorescence-based immunoassays. The core of the optical platform is a plastic
biochip, constituted by 13 microchannels (50 μm high, 600 μm width, 10 mm long) through which the sample flows. The
sensing layer, where the immunochemical reaction takes place, is located on the upper part of each microchannel. The
chip is interrogated with a novel optoelectronic platform, based on fluorescence anisotropy. A line-shaped beam from a
635-nm laser-diode excites perpendicularly the sensing layer and great many of the emitted remains entrapped inside the
chip. The particular shape of the top of the chip allows to guide the emitted fluorescence along the same direction of the
microchannel. The fluorescence which comes out on the lateral side from the chip is collected by a single plastic optical
fibre and sent to an amplified photodiode. The device was characterised by the implementation of the sandwich assay for
CRP and PCT spiked in serum. Limit of quantifications of 4.5 and of 6 μg L-1 in serum solution were achieved for CRP
and PCT, respectively.
The alert did not successfully save. Please try again later.
F. Baldini, L. Bolzoni, A. Giannetti, G. Porro, F. Senesi, C. Trono, "Point of care optical device for sepsis diagnosis," Proc. SPIE 7503, 20th International Conference on Optical Fibre Sensors, 75037J (5 October 2009); https://doi.org/10.1117/12.835418